🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Credicorp to acquire Banmedica's stake in Peru insurance JV

Published 11/01/2024, 07:42 PM
BAP
-

LIMA - Credicorp (NYSE:BAP) Ltd. (NYSE:BAP | BVL:BAP), a prominent financial services holding company in Peru, announced its agreement to purchase Empresas Banmédica's 50% interest in their Peruvian joint venture, a move that will make Credicorp the sole owner of certain medical insurance and corporate health businesses in the country. The transaction is subject to regulatory approvals and customary closing conditions.

The joint venture, formed in December 2014 between Pacífico Compañía de Seguros y Reaseguros S.A. (Pacifico Seguros) and Banmédica, was designed to operate in the private medical insurance market, as well as provide corporate health insurance and medical services in Peru. With this acquisition, Banmédica will cede its half of the venture to Pacifico Seguros and its interest in Pacífico S.A. Entidad Prestadora de Salud (Pacifico EPS) to Grupo Crédito S.A., a subsidiary of Credicorp.

Credicorp aims to enhance its offerings in the insurance and healthcare sectors with this strategic move. The company has expressed its commitment to investing in technology, expanding its reach, and improving service standards to maintain Pacifico Seguros and Pacifico EPS as reliable partners for Peruvian families.

Clients and stakeholders of the affected businesses are expected to see no disruption, with Credicorp assuring continuity of service, policy terms, and administration post-acquisition.

Pacifico EPS, a major player in Peru's corporate health insurance and medical services industry, reported a net income of S/ 205 million in 2023. Pacifico Seguros, also part of the Credicorp group, is a leading insurance provider in Peru with a net income of S/ 810 million in the same year.

This development is based on a press release statement and is a significant step for Credicorp in its mission to foster a sustainable and inclusive economy in Peru by advancing financial inclusion and improving access to insurance and healthcare services.

In other recent news, Credicorp has maintained its strong focus on digital initiatives and disruptive projects, with an aim to enhance its financial performance and shareholder value. Morgan Stanley continues to hold an Equalweight rating for the company, with a price target of $195.00, reflecting Credicorp's commitment to achieving a return on equity (ROE) of 17% in 2024 and 18% by 2025/26. BofA Securities also maintains a Buy rating for Credicorp, with a price target of $190.00, emphasizing the company's digital initiatives which are expected to contribute to an 18% return on average equity and account for 10% of Credicorp's net earnings by 2026.

In parallel developments, Australian auto parts retailer Bapcor rejected two takeover bids from Bain Capital, valued at approximately $1.23 billion, as the offers were deemed not to reflect the fair value of the company. Bapcor has also appointed Angus McKay as the new executive chairman and chief executive officer. These are among the recent developments that are shaping the trajectories of both Credicorp and Bapcor.

InvestingPro Insights

Credicorp's strategic acquisition aligns well with its strong market position and financial performance. According to InvestingPro data, Credicorp boasts a market capitalization of $14.63 billion, reflecting its significant presence in the Peruvian financial sector. The company's P/E ratio of 11.23 suggests that it may be undervalued compared to industry peers, potentially making this acquisition a timely move to enhance shareholder value.

An InvestingPro Tip highlights that Credicorp is a "Prominent player in the Banks industry," which is evident from its expansion in the insurance and healthcare sectors. This diversification strategy could contribute to the company's robust financial health, as indicated by its operating income margin of 42.9% for the last twelve months as of Q2 2024.

Another InvestingPro Tip notes that Credicorp "Has maintained dividend payments for 26 consecutive years," showcasing its commitment to shareholder returns. This is further supported by a current dividend yield of 5.04% and an impressive dividend growth of 37.09% over the last twelve months. Such strong dividend performance may attract investors looking for stable income in the financial services sector.

For readers interested in a deeper analysis, InvestingPro offers 5 additional tips that could provide valuable insights into Credicorp's investment potential and future prospects following this acquisition.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.